Skip to main content

Table 1 Distribution of the various phenotypic variables in cases and controls

From: Effect of apolipoprotein A1 genetic polymorphisms on lipid profiles and the risk of coronary artery disease

 

CAD (n = 300)

Controls (n = 300)

P

Age (years)

56.7 ± 9.9

56.1 ± 9.7

0.45

Sex (Male/Female)

238/62

231/69

0.49

Smoking status (Ever/Never)

84/216

46/254

<0.001

Diabetes (Positive/Negative)

74/226

42/258

0.001

Hypertension (Positive/Negative)

163/137

144/156

0.12

Obesity (Positive/Negative)

87/213

51/249

0.001

Hyperlipidemia (Positive/Negative)

93/207

49/251

<0.001

TG (mg/dL)

192.1 ± 86.7

167.5 ± 77.4

<0.001

TC (mg/dL)

198.7 ± 58.4

185.3 ± 50.1

0.003

HDL-C (mg/dL)

33.7 ± 11.6

38.9 ± 12.9

<0.001

LDL-C (mg/dL)

126.6 ± 37.4

112.9 ± 33.8

<0.001

VLDL-C (mg/dL)

38.4 ± 21.5

33.5 ± 20.3

0.004

ApoA1 (mg/dL)

123.5 ± 22.3

131.9 ± 23.5

<0.001

ApoB (mg/dL)

91.4 ± 27.3

90.6 ± 26.7

0.72

  1. Abbreviations: CAD, coronary artery disease; TG, triglyceride; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; VLDL-C, very-low-density lipoprotein cholesterol; Apo, apolipoprotein